Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Diarrhea × Raloxifene Hydrochloride × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 2 Polycystic Ovary Syndrome 1 Osteoporosis 1 Neoplasms 1 Infertility 1 Diarrhea 1 Anovulation 1

Interventions

Probiotics 2 shosaiko-to 1 maltodextrin 1 bile acid binding proteins 1 Surveys and Questionnaires 1 Sugars 1 Raloxifene Hydrochloride 1 Loperamide 1 Long-Term Synaptic Depression 1 Diet Therapy 1 Calcium Aluminosilicate 1 Anti-Bacterial Agents 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04926545 2024-07-30

XCHT for Irinotecan-Induced Gut Toxicities (Run-in Study)

Guangzhou University of Traditional Chinese Medicine

Phase NA Completed

Diarrhea, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡